The role of telomeres in liver disease.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Progress in Molecular Biology and Translational Science

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/B978-0-12-397898-1.00007-4PMID 24993702
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RAP1 Protects from Obesity through Its Extratelomeric Role Regulating Gene Expression

  2013cited by this paper
• Nontelomeric role for Rap1 in regulating metabolism and protecting against obesity.

  2013cited by this paper
• Transient telomere dysfunction induces chromosomal instability and promotes carcinogenesis.

  2012cited by this paper
• Telomerase gene mutations are associated with cirrhosis formation

  2011cited by this paper
• Telomerase mutation: A genetic risk factor for cirrhosis

  2011cited by this paper
• Constitutional telomerase mutations are genetic risk factors for cirrhosis

  2011cited by this paper
• InTERTpreting telomerase structure and function

  2010cited by this paper
• Telomerase deficiency impairs glucose metabolism and insulin secretion

  2010cited by this paper
• Update on the pathophysiology of liver fibrosis

  2010cited by this paper
• Telomere diseases.

  2009cited by this paper
• A crucial role for adipose tissue p53 in the regulation of insulin resistance

  2009cited by this paper
• Senescence and life span

  2009cited by this paper
• The roles of telomeres and telomerase in β‐cell regeneration

  2009cited by this paper
• Telomere dysfunction and DNA damage checkpoints in diseases and cancer of the gastrointestinal tract.

  2009cited by this paper
• Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

  2008cited by this paper
• Molecular Pathogenesis and Targeted Therapy of Hepatocellular Carcinoma

  2008cited by this paper
• Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation.

  2008cited by this paper
• Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.

  2007cited by this paper
• Protein Composition of Catalytically Active Human Telomerase from Immortal Cells

  2007cited by this paper
• Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1α transcription coactivator

  2007cited by this paper
• Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

  2007cited by this paper
• Telomerase mutations in families with idiopathic pulmonary fibrosis.

  2007cited by this paper
• Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis

  2007cited by this paper
• LIVER FAILURE AND LIVER DISEASE Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis

  2006cited by this paper
• Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression.

  2006cited by this paper
• Reprogramming of replicative senescence in hepatocellular carcinoma-derived cells

  2006cited by this paper
• Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma

  2005cited by this paper
• Liver fibrosis.

  2005cited by this paper
• Rise in Insulin Resistance Is Associated With Escalated Telomere Attrition

  2005cited by this paper
• Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma

  2005cited by this paper
• Contrasting effects of telomere shortening on organ homeostasis, tumor suppression, and survival during chronic liver damage

  2005cited by this paper
• Shelterin: the protein complex that shapes and safeguards human telomeres.

  2005cited by this paper
• Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma

  2004cited by this paper
• Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma.

  2004cited by this paper
• Telomeres and telomerase: new targets for the treatment of liver cirrhosis and hepatocellular carcinoma.

  2004cited by this paper
• Telosome, a Mammalian Telomere-associated Complex Formed by Multiple Telomeric Proteins*

  2004cited by this paper
• Telomeres, Telomerase and Cancer: An Endless Search to Target the Ends

  2004cited by this paper
• Expression of Telomerase RNA Template, but Not Telomerase Reverse Transcriptase, Is Limiting for Telomere Length Maintenance In Vivo

  2004cited by this paper
• Chromosome rearrangements resulting from telomere dysfunction and their role in cancer

  2004cited by this paper
• Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma

  2004cited by this paper
• Growth, telomere dynamics and successful and unsuccessful human aging.

  2003cited by this paper
• Progression of Hepatocellular Carcinoma Differential Impact of Telomere Dysfunction on Initiation and Updated Version

  2003cited by this paper
• Telomere shortening impairs organ regeneration by inhibiting cell cycle re‐entry of a subpopulation of cells

  2003cited by this paper
• A DNA damage checkpoint response in telomere-initiated senescence

  2003cited by this paper
• Molecular pathogenesis of human hepatocellular carcinoma

  2002cited by this paper
• Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis

  2002cited by this paper
• Preferential maintenance of critically short telomeres in mammalian cells heterozygous for mTert

  2002cited by this paper
• Telomerase in the human organism

  2002cited by this paper
• Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis.

  2002cited by this paper
• Telomere dysfunction and evolution of intestinal carcinoma in mice and humans

  2001cited by this paper
• Cellular senescence as a tumor-protection mechanism: the essential role of counting.

  2001cited by this paper
• Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis

  2000cited by this paper
• Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery.

  2000cited by this paper
• Telomere reduction in human liver tissues with age and chronic inflammation.

  2000cited by this paper
• A critical role for telomeres in suppressing and facilitating carcinogenesis.

  2000cited by this paper
• Longevity, stress response, and cancer in aging telomerase-deficient mice.

  1999cited by this paper
• Direct activation of TERT transcription by c-MYC

  1999cited by this paper
• Creation of human tumour cells with defined genetic elements

  1999cited by this paper
• Presence of telomeric G‐strand tails in the telomerase catalytic subunit TERT knockout mice

  1999cited by this paper
• A telomerase component is defective in the human disease dyskeratosis congenita

  1999cited by this paper
• Telomere Length Dynamics and Chromosomal Instability in Cells Derived from Telomerase Null Mice

  1999cited by this paper
• Quantitation of telomerase activity in hepatocellular carcinoma: A possible aid for a prediction of recurrent diseases in the remnant liver

  1998cited by this paper
• Genetic instabilities in human cancers

  1998cited by this paper
• Liver cirrhosis.

  1998cited by this paper
• Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas

  1998cited by this paper
• Extension of life-span by introduction of telomerase into normal human cells.

  1998cited by this paper
• The telomerase reverse transcriptase: components and regulation.

  1998cited by this paper
• The end replication problem: More than one solution

  1997cited by this paper
• hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

  1997cited by this paper
• Telomere shortening and tumor formation by mouse cells lacking telomerase RNA.

  1997cited by this paper
• Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP)

  1997cited by this paper
• Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts.

  1997cited by this paper
• Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease.

  1997cited by this paper
• Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis.

  1997cited by this paper
• Telomerase activity in human germline and embryonic tissues and cells.

  1996cited by this paper
• Telomere shortening in chronic liver diseases.

  1995cited by this paper
• Cryptogenic liver disease in the United States: further evidence for non-A, non-B, and non-C hepatitis.

  1994cited by this paper
• Specific association of human telomerase activity with immortal cells and cancer.

  1994cited by this paper
• Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age.

  1994cited by this paper
• The two-stage mechanism controlling cellular senescence and immortalization.

  1992cited by this paper
• Telomere length predicts replicative capacity of human fibroblasts.

  1992cited by this paper
• Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity.

  1992cited by this paper
• Experimental Models of Hepatic Fibrosis: A Review

  1990cited by this paper
• A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis

  1989cited by this paper
• Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice.

  1989cited by this paper
• A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes.

  1988cited by this paper
• Identification of a specific telomere terminal transferase activity in Tetrahymena extracts.

  1985cited by this paper
• Human cells and aging.

  1968cited by this paper

• Telomerase reactivation is associated with hepatobiliary and pancreatic cancers.

  2020cites this paper
• Activated carbon N-acetylcysteine microcapsule protects against nonalcoholic fatty liver disease in young rats via activating telomerase and inhibiting apoptosis

  2018cites this paper
• Telomere biology and telomerase mutations in cirrhotic patients with hepatocellular carcinoma

  2017cites this paper